Be Familiar With Qulipta for Migraine Prevention

March 2023

Qulipta (atogepant) will be the first oral “gepant” to PREVENT migraine in adults.

It blocks calcitonin gene-related peptide (CGRP)...similar to injectable CGRP antagonists (Aimovig, etc) used for migraine prevention.

Expect Qulipta and injectables to be saved for when patients don’t respond to, or can’t tolerate, first-line meds for preventing migraine...such as beta-blockers (propranolol, etc) or topiramate.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Poison Prevention Provide Strategies to Prevent Poisonings
Pregnancy Stay Alert for Questions About Cough and Cold Meds in Pregnancy
Probiotics Help Navigate Safe Use of Probiotics in Children
COPD Be Prepared to Dispense More Combo Inhalers for COPD
Hair Loss Untangle Meds for Female Pattern Hair Loss
Migraine Be Familiar With Qulipta for Migraine Prevention
Psoriasis Watch for Sotyktu, a New Oral Med for Psoriasis
Med Administration Limit Mishaps With Meds Given Via Feeding Tube
PCOS Keep Meds for PCOS Straight

Be Familiar With Qulipta for Migraine Prevention

Practical advice for a better career, with unlimited access to CE

Table of Contents